Legend Biotech (LEGN) Change in Inventory (2020 - 2025)
Legend Biotech (LEGN) posted Change in Inventory of $5.4 million for Q3 2025, up 292.72% on a QoQ basis from -$2.8 million in Q2 2025, and up 205.75% year-over-year from $1.8 million in Q3 2024.
Legend Biotech (LEGN) has 6 years of Change in Inventory data on file, last reported at $5.4 million in Q3 2025.
- In Q3 2025, Change in Inventory rose 205.75% year-over-year to $5.4 million; the TTM figure through Sep 2025 stood at -$6.9 million (up 52.8% YoY), while the FY2024 annual figure was -$17.2 million, down 35.43% from the prior year.
- Change in Inventory rose to $5.4 million in Q3 2025, from -$2.8 million in the prior quarter.
- Across five years, Change in Inventory topped out at $5.4 million in Q3 2025 and bottomed at -$8.6 million in Q4 2022.
- A 5-year average of -$2.5 million and a median of -$2.8 million in 2025 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2022 — Change in Inventory slumped 7382.61% — and 2025, when it soared 205.75%.
- Year by year, Change in Inventory stood at -$115000.0 in 2021, then slumped by 7382.61% to -$8.6 million in 2022, then jumped by 56.98% to -$3.7 million in 2023, then slumped by 69.23% to -$6.3 million in 2024, then jumped by 185.76% to $5.4 million in 2025.
- The last three Change in Inventory figures came in at $5.4 million (Q3 2025), -$2.8 million (Q2 2025), and -$3.2 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 665.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 97.70 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.32 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.37 Mn |
| Sep 30, 2025 | 5.37 Mn |
| Jun 30, 2025 | -2.79 Mn |
| Jun 30, 2025 | -2.79 Mn |
| Mar 31, 2025 | -3.23 Mn |
| Mar 31, 2025 | -3.23 Mn |
| Dec 31, 2024 | -6.27 Mn |
| Dec 31, 2024 | -6.27 Mn |
| Sep 30, 2024 | -5.08 Mn |
| Sep 30, 2024 | -5.08 Mn |
| Jun 30, 2024 | -1.39 Mn |
| Jun 30, 2024 | -1.39 Mn |
| Mar 31, 2024 | -4.47 Mn |
| Mar 31, 2024 | -4.47 Mn |
| Dec 31, 2023 | -3.70 Mn |
| Dec 31, 2023 | -3.70 Mn |
| Sep 30, 2023 | -3.59 Mn |
| Sep 30, 2023 | -3.59 Mn |
| Jun 30, 2023 | -3.25 Mn |
| Jun 30, 2023 | -3.25 Mn |
| Mar 31, 2023 | -2.17 Mn |
| Mar 31, 2023 | -2.17 Mn |
| Dec 31, 2022 | -8.61 Mn |
| Dec 31, 2022 | -8.61 Mn |
| Sep 30, 2022 | -2.27 Mn |
| Sep 30, 2022 | -2.27 Mn |
| Jun 30, 2022 | -5.26 Mn |
| Jun 30, 2022 | -5.26 Mn |
| Mar 31, 2022 | -1.15 Mn |
| Mar 31, 2022 | -1.15 Mn |
| Dec 31, 2021 | -115,000.00 |
| Dec 31, 2021 | -115,000.00 |
| Sep 30, 2021 | 72,000.00 |
| Sep 30, 2021 | 72,000.00 |
| Jun 30, 2021 | 391,000.00 |
| Jun 30, 2021 | 391,000.00 |
| Mar 31, 2021 | -297,000.00 |
| Mar 31, 2021 | -297,000.00 |
| Dec 31, 2020 | -643,000.00 |
| Dec 31, 2020 | -643,000.00 |
| Sep 30, 2020 | 155,000.00 |
| Sep 30, 2020 | 155,000.00 |